Skip to content
ClinCalc Pro
Menu
Tetracycline antibiotic / off-label SIADH treatment

Demeclocycline hydrochloride

Brand names: Ledermycin

Used in: Hyponatraemia

A tetracycline antibiotic that, in endocrine practice, is used off-label to manage chronic hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Demeclocycline induces a reversible, nephrogenic diabetes-insipidus-like state by reducing renal collecting-duct responsiveness to antidiuretic hormone, thereby promoting free-water excretion and raising serum sodium.

Prescribing in practice

  • The most important safety point is dose-dependent, usually reversible nephrotoxicity, so renal function must be monitored and the drug avoided in significant renal or hepatic impairment.
  • As a tetracycline it causes photosensitivity and is contraindicated in pregnancy, breastfeeding, and young children owing to dental staining and effects on bone.
  • Absorption is reduced by calcium, antacids, iron, and dairy products, which should be separated from dosing.

Monitoring

Monitor serum sodium and renal function closely, titrating to avoid over-rapid sodium correction and detect rising urea or creatinine.

Counselling the patient

  • Avoid taking this with milk, antacids, or iron supplements; separate them by a few hours.
  • Use sun protection as your skin may burn more easily.
  • Report reduced urine output or worsening tiredness, which may indicate kidney effects.

Evidence & guidelines

Demeclocycline is a recognised option for persistent SIADH in standard endocrinology references, used where fluid restriction alone is insufficient.

Reference: Society for Endocrinology hyponatraemia guidance; RCP; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.